Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $203.0100 (-3.73%) ($197.5900 - $210.8100) on Wed. Oct. 17, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.6% (three month average) | RSI | 13 | Latest Price | $203.0100(-3.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.1% a day on average for past five trading days. | Weekly Trend | LGND declines -12.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.3% in a week (0% probabilities). VXX(-16%) TLT(-16%) VIXM(-13%) UUP(-9%) GDXJ(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.3% (StdDev 2.6%) | Hourly BBV | 0 () | Intraday Trend | -3.2% | | | |
|
Resistance Level | $243.53 | 5 Day Moving Average | $204.44(-0.7%) | 10 Day Moving Average | $221.48(-8.34%) | 20 Day Moving Average | $243.53(-16.64%) | To recent high | -26% | To recent low | 1.5% | Market Cap | $3.263b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |